BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31821410)

  • 1. NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload.
    Schnelle M; Sawyer I; Anilkumar N; Mohamed BA; Richards DA; Toischer K; Zhang M; Catibog N; Sawyer G; Mongue-Din H; Schröder K; Hasenfuss G; Shah AM
    Cardiovasc Res; 2021 Jan; 117(1):178-187. PubMed ID: 31821410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced remodelling.
    Zhang M; Mongue-Din H; Martin D; Catibog N; Smyrnias I; Zhang X; Yu B; Wang M; Brandes RP; Schröder K; Shah AM
    Cardiovasc Res; 2018 Mar; 114(3):401-408. PubMed ID: 29040462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the role of extracellular signal-regulated kinases 1 and 2 in volume overload-induced cardiac remodelling.
    Jochmann S; Elkenani M; Mohamed BA; Buchholz E; Lbik D; Binder L; Lorenz K; Shah AM; Hasenfuß G; Toischer K; Schnelle M
    ESC Heart Fail; 2019 Oct; 6(5):1015-1026. PubMed ID: 31322843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.
    Sbroggiò M; Carnevale D; Bertero A; Cifelli G; De Blasio E; Mascio G; Hirsch E; Bahou WF; Turco E; Silengo L; Brancaccio M; Lembo G; Tarone G
    Cardiovasc Res; 2011 Aug; 91(3):456-64. PubMed ID: 21493702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
    Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
    Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
    Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
    Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid peroxisome proliferator-activated receptor gamma deficiency aggravates myocardial infarction in mice.
    Shen ZX; Yang QZ; Li C; Du LJ; Sun XN; Liu Y; Sun JY; Gu HH; Sun YM; Wang J; Duan SZ
    Atherosclerosis; 2018 Jul; 274():199-205. PubMed ID: 29800789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
    Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-dependent metabolic and inotropic responses in the heart are modulated by hydrogen peroxide from NADPH-oxidase isoforms NOX2 and NOX4.
    Steinhorn B; Sartoretto JL; Sorrentino A; Romero N; Kalwa H; Abel ED; Michel T
    Free Radic Biol Med; 2017 Dec; 113():16-25. PubMed ID: 28917508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nox2 dependent redox-regulation of Akt and ERK1/2 to promote left ventricular hypertrophy in dietary obesity of mice.
    Bhatti SN; Li JM
    Biochem Biophys Res Commun; 2020 Jul; 528(3):506-513. PubMed ID: 32507594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
    Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
    Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
    Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
    Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
    Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
    Li J; Yousefi K; Ding W; Singh J; Shehadeh LA
    Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
    You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo cardiac role of migfilin during experimental pressure overload.
    Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B
    Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
    Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
    Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice.
    Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K
    Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.